Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,207.14
(
0.02%
)
News Focus
News Focus
Post# of 48316
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

ash111

Send PM Follow Ignore
Followers 1052
Posts 189434
Boards Moderated 1
Alias Born 06/19/2009

ash111

Re: trading.jeff post# 40123

Friday, 10/13/2017 4:46:19 PM

Friday, October 13, 2017 4:46:19 PM

Post# of 48316
Actually it really doesn't matter who made the announcement. fact is OncoSec Medical is partnering up with Merck & Co., Inc. (NYSE:MRK). Anticipated Study Start Date:
October 15, 2017
https://www.clinicaltrials.gov/ct2/show/NCT03132675?term=NCT03132675.&rank=1

"Under the agreement, OncoSec will sponsor and fund the study and Merck will provide Keytruda"

My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote